Can growth hormone ease knee pain? new pilot study aims to find out
NCT ID NCT07036003
First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This early-stage study tests whether people with knee osteoarthritis can stick to a daily routine of self-injecting recombinant human growth hormone (rHGH) for six weeks. Researchers will track how well participants follow the regimen, along with changes in knee strength, range of motion, and pain. The goal is to see if this approach is practical enough to study further for easing osteoarthritis symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS (KNEE OA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pain drug help you walk better with knee arthritis?
- Can a booklet boost knee surgery recovery?
- Can a simple pressure-sensing device beat foam rolling for knee arthritis pain?
- A gentle pull: could manual traction speed up knee replacement recovery?
- Could a simple tool and exercise ease knee arthritis pain without drugs?
- Can dry needling or taping boost strength training for knee arthritis?